Vanessa Silva Silveira (Vanessa S Silveira)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer gene therapy

Cellular and molecular life sciences : CMLS

Scientific reports

Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto

University of California San Francisco (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Jul 01 2014

Brazil

Professor Doctor :: Genetics

Education History

University of California San Francisco Jan 02 2013 - Dec 30 2013

United States

PHD :: Genetics

Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Jan 02 2010 - Dec 30 2012

Brazil

PHD :: Child Care and Pediatrics

Publications

Eranga Roshan Balasooriya, Qibiao Wu, Haley Ellis, Yuanli Zhen, Bryanna L Norden, Ryan B Corcoran, Adithi Mohan, Eric Martin, Aleksandra Franovic, John S Tyhonas, Matthew Lardy, Kathryn B Grandinetti, Robert Pelham, Liliana Soroceanu, Vanessa Silva Silveira, Nabeel El-Bardeesy
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Eranga Roshan Balasooriya, Qibiao Wu, Haley Ellis, Yuanli Zhen, Bryanna L Norden, Ryan B Corcoran, Adithi Mohan, Eric Martin, Aleksandra Franovic, John S Tyhonas, Matthew Lardy, Kathryn B Grandinetti, Robert Pelham, Liliana Soroceanu, Vanessa Silva Silveira, Nabeel El-Bardeesy
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Verena Silva Santos, Gabriela Maciel Vieira, Mariana Tannús Ruckert, Pamela Viani de Andrade, Luis Fernando Nagano, Mariângela Ottoboni Brunaldi, José Sebastião Dos Santos, Vanessa Silva Silveira
Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation. Cancer gene therapy (2024)
Eranga Roshan Balasooriya, Qibiao Wu, Haley Ellis, Yuanli Zhen, Bryanna L Norden, Ryan B Corcoran, Adithi Mohan, Eric Martin, Aleksandra Franovic, John S Tyhonas, Matthew Lardy, Kathryn B Grandinetti, Robert Pelham, Liliana Soroceanu, Vanessa Silva Silveira, Nabeel El-Bardeesy
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Eranga Roshan Balasooriya, Qibiao Wu, Haley Ellis, Yuanli Zhen, Bryanna L Norden, Ryan B Corcoran, Adithi Mohan, Eric Martin, Aleksandra Franovic, John S Tyhonas, Matthew Lardy, Kathryn B Grandinetti, Robert Pelham, Liliana Soroceanu, Vanessa Silva Silveira, Nabeel El-Bardeesy
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Eranga Roshan Balasooriya, Qibiao Wu, Haley Ellis, Yuanli Zhen, Bryanna L Norden, Ryan B Corcoran, Adithi Mohan, Eric Martin, Aleksandra Franovic, John S Tyhonas, Matthew Lardy, Kathryn B Grandinetti, Robert Pelham, Liliana Soroceanu, Vanessa Silva Silveira, Nabeel El-Bardeesy
The irreversible FGFR inhibitor KIN-3248 overcomes FGFR2 kinase domain mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Qibiao Wu, Haley Ellis, Giulia Siravegna, Alexa G Michel, Bryanna L Norden, Ferran Fece de la Cruz, Eranga Roshan Balasooriya, Yuanli Zhen, Vanessa Silva Silveira, Jianwei Che, Ryan B Corcoran, Nabeel El-Bardeesy
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Vanessa Silva Silveira, Kleiton Silva Borges, Verena Silva Santos, Mariana Tannús Ruckert, Gabriela Maciel Vieira, Elton José Rosas Vasconcelos, Luis Fernando Peinado Nagano, Luiz Gonzaga Tone, Carlos Alberto Scrideli
SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells. Scientific reports 10 (1) (2020)
Mariana Tannús Ruckert, Annet Z Brouwers-Vos, Luis Fernando P Nagano, Jan Jacob Schuringa, Vanessa Silva Silveira
HUWE1 cooperates with RAS activation to control leukemia cell proliferation and human hematopoietic stem cells differentiation fate. Cancer gene therapy 27 (10-11) (2020)
Mariana Tannús Ruckert, Pamela Viani de Andrade, Verena Silva Santos, Vanessa Silva Silveira
Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma. Cellular and molecular life sciences : CMLS 76 (13) (2019)

Vanessa Silva Silveira.css-eqlu8i{font-size:small;padding-left:4px;} (Vanessa S Silveira)

Publication Activity (10 Years)

Top Topics

Top Venues

Vanessa Silva Silveira (Vanessa S Silveira)